MSH6 antibody
Quick Overview for MSH6 antibody (ABIN115271)
Target
See all MSH6 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Specificity
-
MSH6 is a heterodimer of MSH2 binds to DNA containing G/T mismatches. The MSH2-MSH6 complex recognizes a single-based mispair insertion/deletion loop.
Cellular Localization: Nuclear. -
Purification
- Affinity Chromatography.
-
Immunogen
- Synthetic human MSH6 peptide
-
Isotype
- IgG1
-
-
-
-
Application Notes
-
Immunoprecipitation. Western Blot: 1/100-1/500. Immunohistochemistry on Formalin-Fixed Paraffin Embedded Sections: 1/25-1/50 in an ABCmethod (30 to 60 minutes at room temperature (requires high temperature antigenunmasking with 10 mM citrate buffer, pH 6.0 prior to immunostaining). Immunohistochemistry on Frozen Sections. Recommended Positive Control: Tonsil, colon carcinoma
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- MSH6 (MutS Homolog 6 (E. Coli) (MSH6))
-
Alternative Name
- MSH6
-
Background
- An alteration of microsatellite repeats is the result of slippage owing to strand misalignment during DNA replication and is referred to as microsatellite instability (MSI). These defects in DNA repair pathways have been related human carcinogenesis. Studies have shown the mutations of MLH-1, MSH2 and MSH6 genes contribute to the development of sporadic colorectal carcinoma. The repair of mismatch DNA is essential to maintaining the integrity of genetic information over time.Synonyms: DNA mismatch repair protein Msh6, G/T mismatch-binding protein, GTBP, MutS-alpha 160 kDa subunit, p160
-
Gene ID
- 2956
-
NCBI Accession
- NP_000170
-
UniProt
- P52701
-
Pathways
- DNA Damage Repair, Chromatin Binding, Production of Molecular Mediator of Immune Response
Target
-